150 related articles for article (PubMed ID: 33706310)
21. [Expression of autophagy-related proteins in malformations of cortical development].
Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
[TBL] [Abstract][Full Text] [Related]
22. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
[TBL] [Abstract][Full Text] [Related]
23. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
[TBL] [Abstract][Full Text] [Related]
24. Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
Leitner DF; Kanshin E; Askenazi M; Siu Y; Friedman D; Devore S; Jones D; Ueberheide B; Wisniewski T; Devinsky O
PLoS One; 2022; 17(5):e0268597. PubMed ID: 35587487
[TBL] [Abstract][Full Text] [Related]
25. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H
J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787
[TBL] [Abstract][Full Text] [Related]
26. Intraoperative ultrasonography (ioUS) characteristics of focal cortical dysplasia (FCD) type II b.
Prada F; Gennari AG; Del Bene M; Bono BC; Quaia E; D'Incerti L; Villani F; Didato G; Tringali G; DiMeco F
Seizure; 2019 Jul; 69():80-86. PubMed ID: 30999253
[TBL] [Abstract][Full Text] [Related]
27. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
[TBL] [Abstract][Full Text] [Related]
28. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
[TBL] [Abstract][Full Text] [Related]
29. Unilateral holohemispheric central nervous system lesions associated with medically refractory epilepsy in the pediatric population: a retrospective series of hemimegalencephaly and Rasmussen's encephalitis.
Wang DD; Benkli B; Auguste KI; Garcia PA; Sullivan J; Barkovich AJ; Chang EF; Tihan T
J Neurosurg Pediatr; 2014 Dec; 14(6):573-84. PubMed ID: 25303156
[TBL] [Abstract][Full Text] [Related]
30. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
[TBL] [Abstract][Full Text] [Related]
31. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy.
Marsan E; Baulac S
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):6-17. PubMed ID: 29359340
[TBL] [Abstract][Full Text] [Related]
32. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
33. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
[TBL] [Abstract][Full Text] [Related]
34. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
[TBL] [Abstract][Full Text] [Related]
35. Interpreting the Tests of Focal Cortical Dysplasia for Epilepsy Surgery Referral.
Fallah MS; Neupane B; Al Nassar M; RamachandranNair R; Jones KC
Can J Neurol Sci; 2019 Sep; 46(5):559-565. PubMed ID: 31292009
[TBL] [Abstract][Full Text] [Related]
36. Intraoperative Magnetic-Resonance Tomography and Neuronavigation During Resection of Focal Cortical Dysplasia Type II in Adult Epilepsy Surgery Offers Better Seizure Outcomes.
Roessler K; Kasper BS; Heynold E; Coras R; Sommer B; Rampp S; Hamer HM; Blümcke I; Buchfelder M
World Neurosurg; 2018 Jan; 109():e43-e49. PubMed ID: 28951272
[TBL] [Abstract][Full Text] [Related]
37. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.
Yao K; Duan Z; Zhou J; Li L; Zhai F; Dong Y; Wang X; Ma Z; Bian Y; Qi X; Li L
Oncotarget; 2016 Nov; 7(47):76415-76422. PubMed ID: 27811355
[TBL] [Abstract][Full Text] [Related]
38. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
[TBL] [Abstract][Full Text] [Related]
39. Temporal lobe epilepsy and focal cortical dysplasia in children: A tip to find the abnormality.
Bartolini L; Whitehead MT; Ho CY; Sepeta LN; Oluigbo CO; Havens K; Freilich ER; Schreiber JM; Gaillard WD
Epilepsia; 2017 Jan; 58(1):113-122. PubMed ID: 27864929
[TBL] [Abstract][Full Text] [Related]
40. Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies.
Gruber VE; Lang J; Endmayr V; Diehm R; Pimpel B; Glatter S; Anink JJ; Bongaarts A; Luinenburg MJ; Reinten RJ; van der Wel N; Larsen P; Hainfellner JA; Rössler K; Aronica E; Scholl T; Mühlebner A; Feucht M
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):812-825. PubMed ID: 34173252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
